Deutsche Telekom looks overvalued vs. fundamentals, keeping risk elevated. Read here for a detailed investment details of ...

Inspire 500 ETF review: faith-based screens add a quality cost. Inspire screens for "violations" and "excellence". Read here ...

Healthpeak Properties (DOC) benefits from South San Francisco life-science demand and stable outpatient cash flow. See more ...

Calumet (CLMT) poised for big EBITDA growth through 2026–2028 as SAF margins expand and ops improve. Read here for more ...

YieldMax's CHPY ETF beats the S&P 500 with 31% growth since April 2025, driven by semiconductors and strong distributions.

Lionsgate (LION) stock was downgraded to sell after Q2 revenue plunged 42% y/y, leverage hit 6.5x, and valuation stretched.

AI, electrification & smart manufacturing tailwinds plus vacuum recovery and resilient service revenue. See more details here ...

After five days of gains, oil prices came under significant pressure yesterday, with ICE Brent settling 4.15% lower.

Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

Shares MSCI Australia ETF (EWA) outlook: strong 1-year return but lags peers. EWA is close to hitting multi-year resistances.

YPF Sociedad Anonima (YPF) continues to focus on shale in the Vaca Muerta. Read more on what investors should know about this ...

Mastercard (MA) buy case: low odds of rate caps/CCCA, limited revenue/EPS exposure, strong moat and growth from cross-border ...